# Ginkgo Bioworks Holdings, Inc.: Form 8-K, filed Aug 19, 2024

- Company: [Ginkgo Bioworks Holdings, Inc.](/companies/dna.md) (CIK 1830214)
- Form: 8-K
- Filed: 2024-08-19
- Accepted by EDGAR: Aug 19, 2024, 16:06 ET
- Period: 2024-08-19
- Accession: 0001628280-24-037685
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1830214/000162828024037685/dna-20240819.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1830214/000162828024037685/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1830214/000162828024037685/dna-20240819.htm

Filed Aug 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-037685. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.